The Impact of a Diagnostic Strategy for Acute Appendicitis in Children With Acute Abdominal Pain in Primary Care
ISAAK
Optimizing Management of Children Presenting With Acute Abdominal Pain in Primary Care: a Cluster Randomized Controlled Trial Evaluating the Impact of a Clinical Prediction Rule Including C-reactive Protein for Appendicitis
2 other identifiers
interventional
566
1 country
1
Brief Summary
BACKGROUND Acute appendicitis (AA) in an early stage is difficult to distinguish from other (self-limiting) causes of acute abdominal pain (e.g. constipation and gastroenteritis), resulting in missing 19% of children with AA at first presentation in primary care and 70% of non-AA cases among referrals. OBJECTIVE To evaluate the impact of the use of a diagnostic strategy for acute appendicitis (AA), which consists of a clinical prediction rule (cPR) including C-reactive protein point-of-care test (CRP POCT), on referral efficiency in children with acute abdominal pain in primary care, as compared to usual care. STUDY DESIGN This is a cluster randomized controlled trial in primary care with a process evaluation. GPs in the intervention group will use an externally validated cPR based on symptoms and signs selectively followed by a CRP POCT in the medium risk group. GPs from general practices allocated to the control group will provide care and diagnosis as usual, i.e. following recommendations of the Dutch College of GPs guideline 'abdominal pain in children'. STUDY POPULATION Children aged 4 to 18 years presenting to their general practitioner (GP) with acute abdominal pain. OUTCOME MEASURES Primary outcome: referral efficiency (proportion non-referrals in non-AA patients during 30 days follow-up). Secondary outcomes: safety (proportion of referrals in AA patients during the first consultation), proportion of children with CRP-POCT, proportion of children with planned reassessment, child anxiety, parent or child satisfaction, quality of life, and costs.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Mar 2025
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 3, 2024
CompletedFirst Posted
Study publicly available on registry
January 7, 2025
CompletedStudy Start
First participant enrolled
March 6, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 31, 2028
ExpectedStudy Completion
Last participant's last visit for all outcomes
March 1, 2029
November 26, 2025
December 1, 2024
3.1 years
December 3, 2024
November 20, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Referral efficiency
The referral efficiency is defined as the proportion of non-referrals in patients without AA during 30 days follow-up (development of appendicitis beyond this period is extremely unlikely). This corresponds with the specificity of the diagnostic strategy. Medical records of the participating children in the GPs registry, including discharge letters (hospital data), will be screened by the researchers, in order to assess whether children were referred and whether they were or were not diagnosed with AA.
30 days follow-up from baseline
Secondary Outcomes (7)
Safety
30 days follow-up from baseline
Proportion of children with CRP-POCT
Baseline
Proportion of children with planned reassessment
Baseline
Anxiety of child ≥8 years according to the Dutch version of the State-Trait Anxiety Inventory for Children
30 days and 3 months follow-up from baseline
Parent or child satisfaction with management according to the Parental Medical Interview Scale (P-MISS)
30 days follow-up from baseline
- +2 more secondary outcomes
Study Arms (2)
Diagnostic strategy
EXPERIMENTALGPs in the intervention group will use a diagnostic strategy for AA referral, consisting of an externally validated cPR based on seven signs and symptoms, selectively followed by CRP-POCT in children in the medium risk group according to the cPR.
Control
NO INTERVENTIONGPs in the control group provide care as usual, i.e. according to the Dutch College of GPs (NHG) guideline 'Abdominal pain in children', which does not include specific recommendations for AA referral and in which CRP POCT is not recommended. See for details: Detailed description - Usual care.
Interventions
GPs' use of an externally validated cPR followed by CRP-POCT in the medium risk group. See for details: Detailed description - Intervention.
Eligibility Criteria
You may qualify if:
- \- Children aged 4 to 18 years with acute abdominal pain (onset ≤ 7 days) who present at the GP.
You may not qualify if:
- A history of appendectomy
- Current pregnancy
- Traumatic cause of abdominal pain
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University Medical Center Groningenlead
- ZonMw: The Netherlands Organisation for Health Research and Developmentcollaborator
- Leiden University Medical Centercollaborator
- UMC Utrechtcollaborator
Study Sites (1)
University Medical Center Groningen
Groningen, Provincie Groningen, 9700AD, Netherlands
Related Publications (15)
Blok GCGH, Veenstra LMM, van der Lei J, Berger MY, Holtman GA. Appendicitis in children with acute abdominal pain in primary care, a retrospective cohort study. Fam Pract. 2021 Nov 24;38(6):758-765. doi: 10.1093/fampra/cmab039.
PMID: 34278425BACKGROUNDGorter RR, Eker HH, Gorter-Stam MA, Abis GS, Acharya A, Ankersmit M, Antoniou SA, Arolfo S, Babic B, Boni L, Bruntink M, van Dam DA, Defoort B, Deijen CL, DeLacy FB, Go PM, Harmsen AM, van den Helder RS, Iordache F, Ket JC, Muysoms FE, Ozmen MM, Papoulas M, Rhodes M, Straatman J, Tenhagen M, Turrado V, Vereczkei A, Vilallonga R, Deelder JD, Bonjer J. Diagnosis and management of acute appendicitis. EAES consensus development conference 2015. Surg Endosc. 2016 Nov;30(11):4668-4690. doi: 10.1007/s00464-016-5245-7. Epub 2016 Sep 22.
PMID: 27660247BACKGROUNDBlok G, Burger H, van der Lei J, Berger M, Holtman G. Development and validation of a clinical prediction rule for acute appendicitis in children in primary care. Eur J Gen Pract. 2023 Dec;29(1):2233053. doi: 10.1080/13814788.2023.2233053.
PMID: 37578416BACKGROUNDBlok GCGH, Nikkels ED, van der Lei J, Berger MY, Holtman GA. Added value of CRP to clinical features when assessing appendicitis in children. Eur J Gen Pract. 2022 Dec;28(1):95-101. doi: 10.1080/13814788.2022.2067142.
PMID: 35535699BACKGROUNDKharbanda AB, Vazquez-Benitez G, Ballard DW, Vinson DR, Chettipally UK, Dehmer SP, Ekstrom H, Rauchwerger AS, McMichael B, Cotton DM, Kene MV, Simon LE, Zhu J, Warton EM, O'Connor PJ, Kharbanda EO; Clinical Research on Emergency Services and Treatments Network (CREST) and the Critical Care Research Center, HealthPartners Institute. Effect of Clinical Decision Support on Diagnostic Imaging for Pediatric Appendicitis: A Cluster Randomized Trial. JAMA Netw Open. 2021 Feb 1;4(2):e2036344. doi: 10.1001/jamanetworkopen.2020.36344.
PMID: 33560426BACKGROUNDLintula H, Kokki H, Kettunen R, Eskelinen M. Appendicitis score for children with suspected appendicitis. A randomized clinical trial. Langenbecks Arch Surg. 2009 Nov;394(6):999-1004. doi: 10.1007/s00423-008-0425-0. Epub 2008 Oct 8.
PMID: 18841382BACKGROUNDAnsems S, Berger M, Rheenen PV, Vermeulen K, Beugel G, Couwenberg M, Holtman G. Effect of faecal calprotectin testing on referrals for children with chronic gastrointestinal symptoms in primary care: study protocol for a cluster randomised controlled trial. BMJ Open. 2021 Jul 23;11(7):e045444. doi: 10.1136/bmjopen-2020-045444.
PMID: 34301652BACKGROUNDKappen TH, van Loon K, Kappen MA, van Wolfswinkel L, Vergouwe Y, van Klei WA, Moons KG, Kalkman CJ. Barriers and facilitators perceived by physicians when using prediction models in practice. J Clin Epidemiol. 2016 Feb;70:136-45. doi: 10.1016/j.jclinepi.2015.09.008. Epub 2015 Sep 21.
PMID: 26399905BACKGROUNDvan der Wouden JC, Blankenstein AH, Huibers MJ, van der Windt DA, Stalman WA, Verhagen AP. Survey among 78 studies showed that Lasagna's law holds in Dutch primary care research. J Clin Epidemiol. 2007 Aug;60(8):819-24. doi: 10.1016/j.jclinepi.2006.11.010. Epub 2007 Mar 26.
PMID: 17606178BACKGROUNDBjarnason NH, Kampmann JP. Selection bias introduced by the informed consent process. Lancet. 2003 Jun 7;361(9373):1990. doi: 10.1016/S0140-6736(03)13568-4. No abstract available.
PMID: 12801770BACKGROUNDVan den Bruel A, Jones C, Thompson M, Mant D. C-reactive protein point-of-care testing in acutely ill children: a mixed methods study in primary care. Arch Dis Child. 2016 Apr;101(4):382-5. doi: 10.1136/archdischild-2015-309228. Epub 2016 Jan 12.
PMID: 26757989BACKGROUNDAdams G, Gulliford MC, Ukoumunne OC, Eldridge S, Chinn S, Campbell MJ. Patterns of intra-cluster correlation from primary care research to inform study design and analysis. J Clin Epidemiol. 2004 Aug;57(8):785-94. doi: 10.1016/j.jclinepi.2003.12.013.
PMID: 15485730BACKGROUNDSchols AM, Dinant GJ, Cals JW. Point-of-care testing in general practice: just what the doctor ordered? Br J Gen Pract. 2018 Aug;68(673):362-363. doi: 10.3399/bjgp18X698033. No abstract available.
PMID: 30049755BACKGROUNDSchunemann HJ, Oxman AD, Brozek J, Glasziou P, Jaeschke R, Vist GE, Williams JW Jr, Kunz R, Craig J, Montori VM, Bossuyt P, Guyatt GH; GRADE Working Group. Grading quality of evidence and strength of recommendations for diagnostic tests and strategies. BMJ. 2008 May 17;336(7653):1106-10. doi: 10.1136/bmj.39500.677199.AE.
PMID: 18483053BACKGROUNDRIFT Study Group on behalf of the West Midlands Research Collaborative. Appendicitis risk prediction models in children presenting with right iliac fossa pain (RIFT study): a prospective, multicentre validation study. Lancet Child Adolesc Health. 2020 Apr;4(4):271-280. doi: 10.1016/S2352-4642(20)30006-7. Epub 2020 Feb 13.
PMID: 32200936BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Gea A. Holtman, Dr.
University Medical Center Groningen
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- Even though the GP's and children can not be blinded to the allocation, researchers performing the analyses will be blinded to the assigned group.
- Purpose
- DIAGNOSTIC
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 3, 2024
First Posted
January 7, 2025
Study Start
March 6, 2025
Primary Completion (Estimated)
March 31, 2028
Study Completion (Estimated)
March 1, 2029
Last Updated
November 26, 2025
Record last verified: 2024-12
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF, CSR, ANALYTIC CODE
- Time Frame
- After all publications concerning the study are published.
- Access Criteria
- Data will be made available upon reasonable request. In addition, processed and pseudonymized data will be made available upon restricted access (DataverseNL). Meta data will be presented in the UMCG Research Data Catalogue. DOI (Digital Object Identifier) will be shared via publications to make the data more findable.
Processed and pseudonymized data, syntaxes, data documentation and raw data will be made available upon reasonable request.